We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PureTech Health PLC on Thursday said that the US Food & Drug Administration has granted fast track designation to its ...
PureTech Health PLC 09 January 2025 9 January 2025 PureTech Health plc PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) Single agent and...
PureTech Health PLC 08 January 2025 8 January 2025 PureTech Health plc PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference PureTech Health plc (Nasdaq: PRTC, LSE: PRTC...
PureTech Health PLC 06 January 2025 6 January 2025 PureTech Health plc PureTech Appoints UBS as UK Corporate Broker PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the...
LC - Boston, Massachusetts-based biotechnology company - Notes that deupirfenidone, also known as LYT-100, slows lung ...
PureTech Health PLC 16 December 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU 596/ 2014) AS IT FORMS...
PureTech Health PLC 11 December 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BY2Z0H74 Issuer Name PURETECH HEALTH PLC UK or Non-UK Issuer UK 2...
PureTech Health PLC 11 December 2024 11 December 2024 PureTech Health plc PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP...
PureTech Health PLC 09 December 2024 9 December 2024 PureTech Health plc PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the...
Frasers Group PLC has been relegated from the FTSE 100 index in its latest quarterly shuffle alongside two constitue ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -13.8 | -8.97269180754 | 153.8 | 153.8 | 138 | 620710 | 143.75416132 | DE |
4 | -26 | -15.6626506024 | 166 | 178 | 138 | 1078267 | 156.1391277 | DE |
12 | -12.4 | -8.13648293963 | 152.4 | 178 | 138 | 773330 | 160.59438857 | DE |
26 | -35 | -20 | 175 | 186.4 | 138 | 658443 | 158.40655014 | DE |
52 | -67.5 | -32.5301204819 | 207.5 | 238.5 | 138 | 552867 | 177.49789981 | DE |
156 | -151 | -51.8900343643 | 291 | 300 | 138 | 407948 | 198.27417616 | DE |
260 | -150 | -51.724137931 | 290 | 446 | 138 | 335856 | 230.69698806 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions